Melguizo Alonso, Consolación Author
Differentiation in the RD rhabdomyosarcoma cell line after electroporation
- MARCHAL, JA
- HERNANDEZ, MJ
- FERNANDEZ, JE
- PRADOS, JC
- MELGUIZO, C
- ARANEGA, A
European Journal of Cell Biology - 1/05/1995
- CiteScore: 6.8 (2020)
- Scopus
- ORCID
- Web of Science
Differentiation: An encouraging approach to anticancer therapy
- Marchal J.
- Rodríguez-Serrano F.
- Campos J.
- Madeddu R.
- Boulaiz H.
- Martínez-Amat A.
- Carrillo E.
- Caba O.
- Prados J.
- Vélez C.
- Melguizo C.
- Montella A.
- Aránega A.
Italian Journal of Anatomy and Embryology - 1/1/2006
- SJR Quartile: Q3
- CiteScore: 0.3 (2020)
- SJR: 0.193 (2006
- SNIP: 0.383 (2006
- SJR Categories: Anatomy (Q3); Embryology (Q3)
- Scopus
- ORCID
Development of patents and clinical trials on regenerative therapy: Gene therapy
- Prados J.
- Boulaiz H.
- Alvarez P.J.
- Melguizo C.
- Rodríguez-Serrano F.
- Marchal J.A.
- Perán M.
- Caba O.
- Hita F.
- Aranega A.
Recent Patents on Regenerative Medicine - 1/1/2011
- CiteScore: 1.1 (2016)
- SJR Categories: Cell Biology; Developmental Biology; Developmental Neuroscience
- Scopus
- ORCID
Development of chick cardiomyocytes: Modulation of intermediate filaments by basic fibroblast and platelet-derived growth factors
- Velez, C
- Aranega, AE
- Marchal, JA
- Melguizo, C
- Prados, JC
- Carrillo, E
- Aranega, A
Cells Tissues Organs - 1/1/2000
- JCR Quartile: Q3 (2000)
- SJR Quartile: Q2
- JCR Impact Factor: 0.896 (2022)
- Category normalized Impact: 0.125 (2000)
- CiteScore: 4.1 (2020)
- SJR: 0.427 (2000
- SNIP: 0.602 (2000
- SJR Categories: Anatomy (Q2); Histology (Q3)
- Scopus
- ORCID
- Web of Science
Development of biomedical 5-fluorouracil nanoplatforms for colon cancer chemotherapy: Influence of process and formulation parameters
- Pretel E.
- Arias J.
- Cabeza L.
- Melguizo C.
- Prados J.
- Mallandrich M.
- Suñer J.
- Clares B.
INTERNATIONAL JOURNAL OF PHARMACEUTICS - 15/9/2017
- SJR Quartile: Q1
- JCR Impact Factor: 3.862 (2017)
- CiteScore: 8.6 (2020)
- SJR: 1.172 (2017
- SNIP: 1.302 (2017
- JCR 5-year Impact Factor: 4.229
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs
- López-Viota M.
- El-Hammadi M.
- Cabeza L.
- Prados J.
- Melguizo C.
- Ruiz Martinez M.
- Arias J.
- Delgado Á.
AAPS PHARMSCITECH - 1/11/2017
- SJR Quartile: Q1
- JCR Impact Factor: 2.666 (2017)
- CiteScore: 2.46 (2018)
- SJR: 0.752 (2017
- SNIP: 1.122 (2017
- JCR 5-year Impact Factor: 2.882
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)
- Scopus
- ORCID
- Web of Science
Detection of circulating alpha-actinin in non-insulin-dependent diabetics with autonomic dysfunction
- Prados, J
- Melguizo, C
- Aranega, AE
- EscobarJimenez, F
- Cobo, V
- Aranega, A
Cardiology - 1/07/1996
- JCR Impact Factor: 1.791 (2022)
- CiteScore: 2.7 (2020)
- Scopus
- ORCID
- Web of Science
Current status of immunotherapy treatments for pancreatic cancer
- Jimenez-Luna, Cristina
- Prados, Jose
- Ortiz, Raul
- Melguizo, Consolacion
- Torres, Carolina
- Caba, Octavio
Journal of Clinical Gastroenterology - 1/11/2016
- SJR Quartile: Q1
- JCR Impact Factor: 3.328 (2016)
- CiteScore: 5.2 (2020)
- SJR: 1.408 (2016
- SNIP: 1.294 (2016
- JCR 5-year Impact Factor: 3.246
- JCR Categories: GASTROENTEROLOGY & HEPATOLOGY
- SJR Categories: Gastroenterology (Q1)
- Scopus
- ORCID
- Web of Science
Creatine kinase isoenzymes as markers of differentiation in rhabdomyosarcoma cells in culture
- FERNANDEZ, JE
- PRADOS, J
- MELGUIZO, C
- RODRIGUEZ, F
- ALVAREZ, L
- ARANEGA, A
Pathology Research and Practice - 1/12/1994
- CiteScore: 3.6 (2020)
- Scopus
- ORCID
- Web of Science
Contractile regulatory proteins tropomyosin and troponin-T as indicators of the modulatory role of retinoic acid
- Velez, C
- Aranega, AE
- Marchal, JA
- Prados, J
- Melguizo, C
- Carrillo, E
- Boulaiz, H
- Madeddu, R
- Sanchez-Montesinos, I
Cells Tissues Organs - 24/11/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q2
- JCR Impact Factor: 1.757 (2022)
- Category normalized Impact: 0.041 (2003)
- CiteScore: 4.1 (2020)
- SJR: 0.642 (2003
- SNIP: 0.742 (2003
- SJR Categories: Anatomy (Q2); Histology (Q2)
- Scopus
- ORCID
- Web of Science
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador